Drug: |
LOXO-101 |
|||
---|---|---|---|---|
Trial: |
Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors |
|||
Conditions: | Sarcoma | |||
Trial Status: |
Active, not recruiting |
Samsung Medical Center |
Principal Investigator: |
|
---|---|
Contact: |
Keunchil Park, MD, PhD |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
Samsung Medical Center Website: |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.